PATHOLOGY RESEARCH AND PRACTICE

Scope & Guideline

Connecting Theory and Practice in Pathology

Introduction

Welcome to the PATHOLOGY RESEARCH AND PRACTICE information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of PATHOLOGY RESEARCH AND PRACTICE, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0344-0338
PublisherELSEVIER GMBH
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 1978 to 2024
AbbreviationPATHOL RES PRACT / Pathol. Res. Pract.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressHACKERBRUCKE 6, 80335 MUNICH, GERMANY

Aims and Scopes

The journal 'Pathology Research and Practice' focuses on advancing the understanding of pathological processes and their implications for various diseases through rigorous research and clinical studies. It aims to publish high-quality research that contributes to the field of pathology, with a particular emphasis on molecular mechanisms, diagnostic advancements, and therapeutic implications.
  1. Molecular Pathology:
    Research exploring the molecular mechanisms underlying diseases, including cancer genomics, epigenetics, and the role of non-coding RNAs in tumor progression.
  2. Histopathological Studies:
    Detailed examinations of tissue specimens to identify disease patterns, tumor characteristics, and their correlation with clinical outcomes.
  3. Diagnostic Innovations:
    Development and validation of novel biomarkers and diagnostic techniques, including immunohistochemical markers and next-generation sequencing applications.
  4. Cancer Immunology:
    Studies focused on the tumor microenvironment, immune evasion mechanisms, and the role of immune checkpoints in cancer progression and therapy.
  5. Therapeutic Research:
    Research on therapeutic targets, including drug resistance mechanisms, and the potential of novel treatment modalities such as immunotherapy and gene therapy.
The journal has recently seen a surge in interest in several emerging themes, reflecting the evolving landscape of pathology research. These trends indicate a shift towards more complex and integrative approaches to understanding diseases.
  1. Role of Non-coding RNAs:
    Increasing research on non-coding RNAs, particularly their roles in cancer progression, chemoresistance, and as potential therapeutic targets, showcases the expanding understanding of RNA biology in pathology.
  2. Tumor Microenvironment Studies:
    A growing emphasis on the tumor microenvironment, including interactions between cancer cells and stromal components, is evident, highlighting its significance in cancer biology and treatment responses.
  3. Artificial Intelligence and Digital Pathology:
    The integration of artificial intelligence and machine learning techniques in pathology for diagnostic purposes is a rapidly emerging theme, showcasing the potential for enhanced accuracy and efficiency in diagnostics.
  4. Immunotherapy and Cancer Treatment:
    Research focusing on immunotherapeutic strategies, including the exploration of immune checkpoint inhibitors and their roles in various cancers, is gaining momentum, reflecting a significant shift in cancer treatment paradigms.
  5. Personalized Medicine Approaches:
    Emerging studies on personalized medicine in pathology, particularly the use of genetic and epigenetic profiling to tailor treatments, are becoming increasingly prevalent.

Declining or Waning

While the journal continues to explore a diverse range of topics, certain areas of focus have seen a decline in prominence over recent years. These waning scopes may reflect shifts in research trends or emerging priorities within the field of pathology.
  1. Traditional Histopathology Techniques:
    There has been a noticeable decrease in studies emphasizing traditional histopathological techniques without molecular or genetic components, as the field moves towards more integrative approaches that combine histology with molecular data.
  2. Single Disease Focus:
    Research centered exclusively on individual diseases without consideration of broader implications or multi-disease comparisons is becoming less common, as interdisciplinary studies gain traction.
  3. Basic Pathophysiology Studies:
    Papers focusing solely on basic pathophysiological mechanisms without direct clinical or therapeutic relevance are less frequently published, indicating a trend towards translational research.

Similar Journals

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS

Advancing the Science of Diagnostic Innovation
Publisher: SAGE PUBLICATIONS LTDISSN: 0393-6155Frequency: 4 issues/year

Welcome to the International Journal of Biological Markers, a distinguished publication under SAGE Publications Ltd that has been a vital resource in the fields of Cancer Research, Clinical Biochemistry, Oncology, and Pathology and Forensic Medicine since its inception in 1986. With a commitment to disseminating high-quality research, the journal enjoys a robust impact highlighted by its Q2 and Q3 rankings across multiple categories in 2023, as evidenced by its Scopus rankings placing it in respectable percentiles. Based in Italy, this journal serves a global audience of researchers, clinicians, and students eager to keep abreast of the latest discoveries involving biological markers and their applications in medicine. Emphasizing rigorous peer review and scholarly integrity, the International Journal of Biological Markers plays a crucial role in advancing knowledge that can significantly impact clinical practices and enhance patient care.

NAR Cancer

Pioneering insights for a cancer-free future.
Publisher: OXFORD UNIV PRESSISSN: 2632-8674Frequency: 4 issues/year

NAR Cancer, published by Oxford University Press, is a pioneering open access journal established to advance the rapidly evolving field of cancer research. Since its inception in 2019, this journal has gained substantial recognition, achieving a prestigious Q1 ranking in both Cancer Research and Oncology categories as of 2023. With a focused objective to disseminate high-quality research, reviews, and insights into innovative cancer treatments and diagnostics, NAR Cancer serves as an essential platform for researchers, healthcare professionals, and students alike. The journal is accessible for all since it became open access in 2020, ensuring a global reach and impact. Positioned in the competitive landscape of oncology, with impressive Scopus rankings, it offers a unique opportunity for contributors to share their work with an engaged and interdisciplinary audience. With a commitment to excellence, NAR Cancer is dedicated to driving forward the understanding and management of cancer worldwide.

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY

Elevating Standards in Surgical Diagnostics
Publisher: SAGE PUBLICATIONS INCISSN: 1066-8969Frequency: 6 issues/year

International Journal of Surgical Pathology is a distinguished peer-reviewed journal published by SAGE Publications Inc since 1993, specializing in the intricate fields of surgical pathology, anatomy, and surgery. With an ISSN of 1066-8969 and an E-ISSN of 1940-2465, this journal has been at the forefront of disseminating vital research that helps shape clinical practices and understanding in surgical diagnostics. Ranked in the Q2 category for Anatomy and garnering Q3 status in Pathology and Forensic Medicine as well as Surgery, the journal holds a commendable position within its field as reflected by its Scopus ranks. The impact factor underscores its influence and relevance, making it an essential resource for researchers, professionals, and students alike, looking to stay abreast of advancements in surgical pathology. However, please note that the journal does not currently offer open access options. As it converges through the years from 1993 to 2024, the International Journal of Surgical Pathology continues to uphold its commitment to excellence in medical research.

GENE

Illuminating the Path of Genetic Advancements
Publisher: ELSEVIERISSN: 0378-1119Frequency: 48 issues/year

GENE, an esteemed journal published by Elsevier, serves as a vital resource for researchers and professionals in the fields of genetics and medicine. With an ISSN of 0378-1119 and an E-ISSN of 1879-0038, this scholarly journal has been at the forefront of genetic research since its inception in 1976 and is set to continue until 2025. Situated in the Netherlands, GENE is recognized for its significant contributions, reflected in its Q2 ranking in both Genetics and Miscellaneous Medicine categories for 2023. This positioning within the Scopus rankings demonstrates its impact and relevance in a competitive field, where it holds the rank of #129 out of 347 in Genetics, placing it within the 62nd percentile. Although it does not offer open access options, GENE provides invaluable insight into contemporary genetic research, thereby fostering academic discussions and advancements. Researchers, professionals, and students alike will find GENE an essential platform for disseminating knowledge and exploring innovative developments in genetics and associated sciences.

Journal of Pathology and Translational Medicine

Bridging Theory and Practice in Medical Science
Publisher: KOREAN SOC PATHOLOGISTSISSN: 2383-7837Frequency: 6 issues/year

The Journal of Pathology and Translational Medicine, published by the Korean Society of Pathologists, is a distinguished peer-reviewed Open Access journal that has been at the forefront of advancing the field of pathology and histology since its inception in 1985. With an established ISSN of 2383-7837 and an E-ISSN of 2383-7845, the journal serves as a vital platform for disseminating high-quality research, fostering collaboration among professionals and offering valuable insights into both clinical applications and theoretical advancements. Recognized for its influence in the field, it holds a commendable Q2 ranking in both Histology and Pathology & Forensic Medicine categories in 2023, and ranks #52/208 in Scopus for Medicine – Pathology and Forensic Medicine, demonstrating its impact and reach within the academic community. Located in South Korea at 1209 Gwanghwamun Officia, 92 Saemunan-ro, Jongno-gu, Seoul 03186, this journal not only caters to researchers and professionals but also supports students striving to deepen their understanding of pathology. Join the growing body of knowledge and stay updated with the latest findings in this essential field of study through the journal's open access format, promoting worldwide accessibility and engagement.

JOURNAL OF GENE MEDICINE

Innovating Molecular Medicine for Tomorrow
Publisher: WILEYISSN: 1099-498XFrequency: 12 issues/year

The Journal of Gene Medicine, published by Wiley, stands as a pivotal resource in the field of gene therapy and molecular medicine, with a rich history of dissemination of impactful research since its inception in 1998. With an ISSN of 1099-498X and an E-ISSN of 1521-2254, this esteemed journal plays a crucial role in advancing our understanding of genetics and drug discovery, reflected in its impressive 2023 Scopus rankings where it holds a Q2 classification in Drug Discovery and Q3 in several genetics-related categories. The journal aims to facilitate the exchange of high-quality research findings that bridge the gap between laboratory and clinical applications, making it an essential platform for researchers, academics, and healthcare professionals committed to the forefront of genetic innovation. Although it does not currently offer open access options, its reputation for rigorous peer review ensures that all published work meets the highest academic standards, providing a reliable reference for scientific inquiry in the United States and beyond. As the field rapidly evolves, the Journal of Gene Medicine remains at the helm, guiding future discoveries with its influential publications and comprehensive insights.

PATHOLOGY INTERNATIONAL

Navigating the Evolving Landscape of Pathological Insights
Publisher: WILEYISSN: 1320-5463Frequency: 12 issues/year

PATHOLOGY INTERNATIONAL, published by WILEY, stands as a distinguished journal in the field of pathology and forensic medicine, serving as an essential resource for researchers, clinicians, and students alike. With its ISSN 1320-5463 and E-ISSN 1440-1827, PATHOLOGY INTERNATIONAL has established itself since its inception in 1951, navigating through an evolving landscape in medical science with insights and breakthroughs up to 2024. It holds a commendable Q2 ranking in both the Medicine (miscellaneous) and Pathology and Forensic Medicine categories, indicating its robust influence and quality within these fields, as evidenced by its placement in the 70th percentile of Scopus rankings. While currently not an open-access journal, it provides access options that ensure valuable research remains available to the academic community. PATHOLOGY INTERNATIONAL commits to advancing the discipline through pioneering research articles, comprehensive reviews, and expert opinions that push the boundaries of understanding in pathology, thereby supporting the enhancement of diagnostic and therapeutic practices.

Malaysian Journal of Pathology

Fostering innovation in medical research and practice.
Publisher: MALAYSIAN JOURNAL PATHOLOGYISSN: 0126-8635Frequency: 3 issues/year

Malaysian Journal of Pathology, published by the MALAYSIAN JOURNAL PATHOLOGY, stands as a pivotal resource in the fields of pathology and medicine, contributing rich insights since its inception in 1979. This peer-reviewed journal, based in Malaysia, is dedicated to disseminating original research, review articles, and case studies that advance the understanding of disease mechanisms and diagnostics. With a current impact factor reflecting its ranked positioning—Q4 in Cell Biology, Q4 in Histology, and Q3 in both Miscellaneous Medicine and Pathology & Forensic Medicine—this journal serves as an essential platform for researchers, clinicians, and students alike. Although it operates without open access, its scholarly rigor and contributions are well recognized, holding ranks such as #84 in Pathology and Forensic Medicine according to Scopus. The Malaysian Journal of Pathology is committed to fostering innovation and excellence in medical research, making it an invaluable tool for professionals seeking to stay abreast of significant advancements in the pathology domain.

VIRCHOWS ARCHIV

Exploring Pioneering Research in Health Sciences
Publisher: SPRINGERISSN: 0945-6317Frequency: 12 issues/year

Virchows Archiv, published by Springer, is an esteemed journal dedicated to the fields of Medicine and Pathology, featuring high-quality research from various domains including Cell Biology and Molecular Biology. With its inception dating back to 1947, Virchows Archiv has been a pivotal platform for advancing the understanding of pathological and forensic medicine. As evidenced by its impressive Scopus rank, placing it within the top 15% of journals in Pathology and Forensic Medicine, it continues to maintain a strong presence with a Q1 classification in its category as of 2023. Although it does not offer Open Access options, the journal remains critical for researchers and professionals seeking to publish and access pioneering findings that can impact clinical practices and the academic community. The journal’s rigorous peer-review process ensures that only the highest quality research is disseminated, making it an essential resource for those engaged in the ever-evolving fields of health and biological sciences.

Turkish Journal of Pathology

Your Gateway to Cutting-Edge Pathological Discoveries
Publisher: FEDERATION TURKISH PATHOLOGY SOCISSN: 1018-5615Frequency: 3 issues/year

Turkish Journal of Pathology, published by the Federation Turkish Pathology Society, stands as a vital platform for disseminating high-quality research in the field of pathology and forensic medicine. With an ISSN of 1018-5615 and an E-ISSN of 1309-5730, this journal has been an open-access publication since 2013, ensuring that cutting-edge findings are readily available to the global community. Based in Turkey, it aims to contribute significantly to the advancement of pathology as it converges from 2010 to 2024, currently holding a Q3 quartile ranking in its category according to 2023 metrics. As it ranks #129 out of 208 in the Scopus database for Medicine, Pathology, and Forensic Medicine, it offers researchers, professionals, and students invaluable insights and innovative studies that address critical developments in the field. The Turkish Journal of Pathology fosters collaboration and knowledge-sharing, making it an essential resource for anyone involved in pathology research and practice.